Blinded by Design: When AI Stops Thinking and Starts Remembering
A name can do a suspicious amount of work. Give an LLM a table of colorectal cancer gene candidates and ask it to rank the best drug targets. When the gene names are visible, KRAS lands at #1. The model justifies the choice with a confident reference to “proven therapeutic tractability via covalent RAS inhibitors.” Sensible enough, if the task is to combine the supplied table with the model’s accumulated biomedical knowledge. ...